The series E operation allows the company's valuation to double, reaching 2,700 million euros. The new funds will allow Alan's business to continue growing in France, Belgium and Spain.
The health of employees is an issue that is of increasing concern to companies and more so in recent years due to the effects of the pandemic. To cover this need, the role of firms like Alan makes more sense than ever. The business of the company